Product Description: Cinoxacin (Compound 64716), a synthetic antimicrobial related to the quinolone class of orally active antibacterial agent. Cinoxacin has antibacterial activity against many gram-negative aerobic bacteria and inhibits bacterial DNA synthesis. Cinoxacin can be used for the research of urinary tract infections and bacterial prostatitis[1][2].
Applications: COVID-19-immunoregulation
Formula: C12H10N2O5
References: [1]Scavone JM, et al. Cinoxacin: mechanism of action, spectrum of activity, pharmacokinetics, adverse reactions, and therapeutic indications. Pharmacotherapy. 1982 Sep-Oct;2(5):266-72. /[2]W E Wick, et al. Compound 64716, a new synthetic antibacterial agent. Antimicrob Agents Chemother. 1973 Oct;4(4):415-20.
CAS Number: 28657-80-9
Molecular Weight: 262.22
Compound Purity: 99.99
Research Area: Infection
Solubility: DMSO : 8.33 mg/mL (ultrasonic)
Target: Antibiotic;Bacterial;DNA/RNA Synthesis
English
Deutsch
